List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 53 studies with search of: GW433908 OR FOSAMPRENAVIR [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed
Has Results 		A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: fosamprenavir (GW433908);   Drug: ritonavir
2 Active, not recruiting Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GW433908;   Drug: ritonavir
3 Unknown † Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
4 Recruiting HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Conditions: Chronic HIV Infection;   HCV Coinfection
Intervention: Drug: Fosamprenavir
5 Active, not recruiting 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
6 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
7 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
8 Completed
Has Results 		A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Half-boosted Fosamprenavir;   Drug: Full Boosted Fosamprenavir
9 Completed Fosamprenavir Versus Other Protease Inhibitors
Conditions: Human Immunodeficiency Virus I Infection;   HIV Infection
Intervention: Drug: fosamprenavir
10 Completed
Has Results 		HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Condition: HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
11 Unknown † Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Conditions: Hypertriglyceridemia;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
12 Unknown † Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
13 Completed Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
Conditions: Human Immunodeficiency Virus I Infection;   HIV Infection
Intervention: Drug: No intervention; Observational study
14 Completed Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
15 Completed GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: GSK1349572;   Drug: Fosamprenavir;   Drug: Ritonavir
16 Completed Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Condition: HIV Infections
Interventions: Drug: fosamprenavir;   Drug: COMBIVIR;   Drug: ritonavir;   Drug: TRIZIVIR
17 Completed
Has Results 		A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Condition: HIV Infection
Interventions: Drug: ritonavir;   Drug: fosamprenavir
18 Completed "The Once A Day Protease Inhibitor Regimens"
Conditions: HIV Infections;   Antiretroviral Therapy
Interventions: Drug: ritonavir-boosted atazanavir;   Drug: ritonavir-boosted fosamprenavir
19 Active, not recruiting Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
Conditions: Opioid Dependency;   HIV Infections
Interventions: Drug: Fosamprenavir/Ritonavir;   Drug: Darunavir/Ritonavir;   Drug: Rifampin;   Drug: Rifabutin;   Drug: Buprenorphine
20 Unknown † Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: GW433908

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services